Growing antimicrobial resistance of Shigella isolates

被引：97

作者：

Ashkenazi, S

Levy, I

Kazaronovski, V

Samra, Z

机构：

[1] Schneider Childrens Med Ctr Israel, Dept Paediat A, IL-49202 Petah Tiqwa, Israel

[2] Schneider Childrens Med Ctr Israel, Infect Dis Unit, IL-49202 Petah Tiqwa, Israel

[3] Felsenstein Med Res Ctr, Petah Tiqwa, Israel

[4] Tel Aviv Univ, Sackler Fac Med, IL-69978 Tel Aviv, Israel

[5] Rabin Med Ctr, Dept Clin Microbiol, Petah Tiqwa, Israel

来源：

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY | 2003年 / 51卷 / 02期

关键词：

diarrhoea; shigellosis; antibiotic therapy;

D O I：

10.1093/jac/dkg080

中图分类号：

R51 [传染病];

学科分类号：

100401 ;

摘要：

Appropriate antibiotic treatment of shigellosis depends on identifying resistance patterns. By studying Shigella isolates in central Israel from 1998 to 2000, and comparing with the period 1991-1992, we identified a significantly increased resistance to tetracycline (from 23% to 87%, P < 0.00001), high resistance to trimethoprim-sulfamethoxazole (94%) and ampicillin (85%) and emerging resistance to quinolones (0.5-2%). These data mandate local monitoring of resistance and its consideration in empirical therapy.

引用

页码：427 / 429

页数：3

共 10 条

[1]

[Anonymous], 2000, M2A7 NCCLS

[2] INCREASING ANTIMICROBIAL RESISTANCE OF SHIGELLA ISOLATES IN ISRAEL DURING THE PERIOD 1984 TO 1992 [J].